Effect of exercise training and isoflavones on hepatic steatosis in overweight postmenopausal women

Climacteric

Volumn 16, Issue 1, 2012, Pages 88-95

  Barsalani, R ^a,b   Riesco, E ^a,b   Lavoie, J M ^c   Dionne, I J ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Estrogens; Hepatic Enzymes; Menopause; Mixed Exercise Training; Non Alcoholic Fatty Liver Disease; Phytoestrogens

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; ISOFLAVONE DERIVATIVE; PLACEBO;

ADD ON THERAPY; ADULT; AEROBIC EXERCISE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY COMPOSITION; CALORIC INTAKE; DIET SUPPLEMENTATION; DISEASE MARKER; DOUBLE BLIND PROCEDURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OBESITY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; RISK REDUCTION;

EID: 84872440184     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2012.662251     Document Type: Article

References (50)

1. Garg A, Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab 2002;87: 3019-22 (Pubitemid 34816337)
2. Shin WY, Jung DH, Shim JY, Lee HR. The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. Platelets 2011;22: 442-6
3. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005;16: 421-7 (Pubitemid 41017626)
4. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006;22: 437-43 (Pubitemid 44774047)
5. Rubinstein E, Lavine JE, Schwimmer JB. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis 2008;28: 380-5
6. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122: 1649-57 (Pubitemid 34533559)
7. Clark JM. Weight loss as a treatment for nonalcoholic fatty liver disease. J Clin Gastroenterol 2006;40(Suppl 1):S39-43 (Pubitemid 44309542)
8. Volzke H, Schwarz S, Baumeister SE, et al. Menopausal status and hepatic steatosis in a general female population. Gut 2007;56: 594-5 (Pubitemid 46580520)
9. Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21: 138-43
10. Barsalani R, Chapados NA, Lavoie JM. Hepatic VLDL-TG production and MTP gene expression are decreased in ovariectomized rats: effects of exercise training. Horm Metab Res 2010;42: 860-7
11. Nemoto Y, Toda K, Ono M, et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest 2000;105: 1819-25 (Pubitemid 30421763)
12. Hewitt KN, Pratis K, Jones ME, Simpson ER. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 2004;145: 1842-8 (Pubitemid 38402393)
13. Hagymasi K, Reismann P, Racz K, Tulassay Z. Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease. Orv Hetil 2009;150: 2173-81
14. Green JS, Stanforth PR, Rankinen T, et al. The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study. Metabolism 2004;53: 1192-6 (Pubitemid 39140756)
15. Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas 2010;66: 333-43
16. McKenzie J, Fisher BM, Jaap AJ, Stanley A, Paterson K, Sattar N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol (Oxf) 2006;65: 40-4
17. Frith J, Newton JL. Liver disease in older women. Maturitas 2010;65: 210-14
18. Clarkson TB. Soy phytoestrogens: what will be their role in postmenopausal hormone replacement therapy? Menopause 2000;7: 71-5 (Pubitemid 30151393)
19. Choquette S, Riesco E, Cormier E, Dion T, Aubertin-Leheudre M, Dionne IJ. Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial. Br J Nutr 2011;105: 1199-209
20. Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study. Menopause 2007;14: 624-9 (Pubitemid 47051954)
21. Foth D, Nawroth F. Effect of soy supplementation on endogenous hormones in postmenopausal women. Gynecol Obstet Invest 2003;55: 135-8 (Pubitemid 36928631)
22. Riesco E, Choquette S, Audet M, Lebon J, Tessier D, Dionne IJ. Effect of exercise training combined with phytoestrogens on adipokines and C-reactive protein in postmenopausal women: a randomized trial. Metabolism 2012;61: 273-80
23. Demonty I, Lamarche B, Jones PJ. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr Rev 2003;61: 189-203 (Pubitemid 37259937)
24. Kim MH, Park JS, Jung JW, Byun KW, Kang KS, Lee YS. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int J Obes (Lond) 2011;35: 1019-30
25. Lavoie JM, Pighon A. NAFLD, estrogens, and physical exercise: the animal model. J Nutr Metab 2012;2012: 914-38
26. Finucane FM, Sharp SJ, Purslow LR, et al. The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial. Diabetologia 2010;53: 624-31
27. Pighon A, Barsalani R, Yasari S, Prud'homme D, Lavoie JM. Does exercise training prior to ovariectomy protect against liver and adipocyte fat accumulation in rats? Climacteric 2010;13: 238-48
28. Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6: 33
29. Riesco E, Aubertin-Leheudre M, Maltais ML, Audet M, Dionne IJ. Synergic effect of phytoestrogens and exercise training on cardiovascular risk profile in exercise-responder postmenopausal women: a pilot study. Menopause 2010;17: 1035-9
30. American College of Sports Medicine, Whaley MH, Armstrong LE. ACSM's Guidelines for Exercise Testing and Prescription, 7th edn. Philadelphia: Lippincott Williams & Wilkins, 2006
31. Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn 1957;35: 307-15
32. Wisloff U, Stoylen A, Loennechen JP, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007;115: 3086-94 (Pubitemid 46956498)
33. Choi JS, Song J. Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats. Nutrition 2009;25: 676-85
34. Ricci G, Bersani G, Rossi A, Pigo F, De Fabritiis G, Alvisi V. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg 2008;18: 1438-42
35. Thamer C, Tschritter O, Haap M, et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res 2005;37: 246-51 (Pubitemid 40756347)
36. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986;292: 13-15 (Pubitemid 16175875)
37. Hamden K, Carreau S, Ayadi F, Masmoudi H, El Feki A. Inhibitory effect of estrogens, phytoestrogens, and caloric restriction on oxidative stress and hepato-toxicity in aged rats. Biomed Environ Sci 2009;22: 381-7
38. Kim SH, Lee JW, Im JA, Hwang HJ. Increased gammaglutamyltransferase and decreased total bilirubin are associated with metabolic syndrome in Korean postmenopausal women. Clin Chem Lab Med 2010;48: 1623-8
39. Goto S, Naito H, Kaneko T, Chung HY, Radak Z. Hormetic effects of regular exercise in aging: correlation with oxidative stress. Appl Physiol Nutr Metab 2007;32: 948-53
40. Devries MC, Samjoo IA, Hamadeh MJ, Tarnopolsky MA. Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women. Obesity (Silver Spring) 2008;16: 2281-8
41. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006;16: 1278-86 (Pubitemid 44671797)
42. Rector RS, Thyfault JP, Morris RT, et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 2008;294:G619-26 (Pubitemid 351468778)
43. Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin Liver Dis 2004;8: 639-71, xi (Pubitemid 39141147)
44. Adiels M, Olofsson SO, Taskinen MR, Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28: 1225-36
45. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 2004;134: 3277-83 (Pubitemid 39602998)
46. Magkos F. Exercise and fat accumulation in the human liver. Curr Opin Lipidol 2010;21: 507-17
47. Cree MG, Newcomer BR, Katsanos CS, et al. Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab 2004;89: 3864-71 (Pubitemid 39071486)
48. Kim MH, Kang KS, Lee YS. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Br J Nutr 2010;104: 1333-42
49. Pighon A, Gutkowska J, Jankowski M, Rabasa-Lhoret R, Lavoie JM. Exercise training in ovariectomized rats stimulates estrogeniclike effects on expression of genes involved in lipid accumulation and subclinical inflammation in liver. Metabolism 2011;60: 629-39
50. Calori G, Lattuada G, Ragogna F, et al. Fatty liver index and mortality: The Cremona Study in the 15th year of follow-up. Hepatology 2011;54: 145-52